CLINICAL_TRIALS
trial_result
· 2025-12-05
Clinical Trial Update: Ripretinib (QINLOCK®) According to Current SmPC
Summary
Ripretinib for Gastrointestinal stromal tumor has a completed trial (NCT06619275). The update indicates that the trial findings are consistent with the current …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: iOMEDICO AG | Conditions: GIST - Gastrointestinal Stromal Tumor | Status: COMPLETED